Stock Track | SHINEWAY PHARM Soars 5.09% Intraday on Strong Earnings, Procurement Wins and Dividend Announcement

Stock Track

03/27

SHINEWAY PHARM's stock price soared 5.09% during intraday trading on Friday, following the release of its annual financial results and other positive corporate announcements.

The company reported an annual profit increase of 13.1% to 950 million yuan for the fiscal year ended December 31, 2025, despite a decrease in overall revenue. Furthermore, the group successfully secured bids for eight key products in the National Chinese Patent Medicine Purchasing Alliance's centralized procurement program, covering major therapeutic areas. This success is expected to enhance future market demand and sales potential for its products.

Additionally, the company declared a first interim dividend of RMB 0.43 per share for the 2026 financial year, providing a return to shareholders. These combined positive developments likely contributed to increased investor confidence and the significant upward movement in the stock price.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1110490559"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1110490559\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1110490559?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 13:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110490559","market":"us","top_or_hot":-1,"title":"Stock Track | SHINEWAY PHARM Soars 5.09% Intraday on Strong Earnings, Procurement Wins and Dividend Announcement","media":"Stock Track","content":"<p>SHINEWAY PHARM's stock price soared 5.09% during intraday trading on Friday, following the release of its annual financial results and other positive corporate announcements.</p><p>The company reported an annual profit increase of 13.1% to 950 million yuan for the fiscal year ended December 31, 2025, despite a decrease in overall revenue. Furthermore, the group successfully secured bids for eight key products in the National Chinese Patent Medicine Purchasing Alliance's centralized procurement program, covering major therapeutic areas. This success is expected to enhance future market demand and sales potential for its products.</p><p>Additionally, the company declared a first interim dividend of RMB 0.43 per share for the 2026 financial year, providing a return to shareholders. These combined positive developments likely contributed to increased investor confidence and the significant upward movement in the stock price.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | SHINEWAY PHARM Soars 5.09% Intraday on Strong Earnings, Procurement Wins and Dividend Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | SHINEWAY PHARM Soars 5.09% Intraday on Strong Earnings, Procurement Wins and Dividend Announcement\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-03-27 13:09</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>SHINEWAY PHARM's stock price soared 5.09% during intraday trading on Friday, following the release of its annual financial results and other positive corporate announcements.</p><p>The company reported an annual profit increase of 13.1% to 950 million yuan for the fiscal year ended December 31, 2025, despite a decrease in overall revenue. Furthermore, the group successfully secured bids for eight key products in the National Chinese Patent Medicine Purchasing Alliance's centralized procurement program, covering major therapeutic areas. This success is expected to enhance future market demand and sales potential for its products.</p><p>Additionally, the company declared a first interim dividend of RMB 0.43 per share for the 2026 financial year, providing a return to shareholders. These combined positive developments likely contributed to increased investor confidence and the significant upward movement in the stock price.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02877","symbol_name":"神威藥業","start_time":0,"source_url":"","article_id":"1110490559","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110490559","pubTimestamp":1774588143,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"SHINEWAY PHARM's stock price soared 5.09% during intraday trading on Friday, following the release of its annual financial results and other positive corporate announcements.The company reported an...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02877":"神威药业"},"translate_title":"个股轨迹|神威药业盘中大涨5.09%盈利强劲、采购中标及派息公告","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02877":1},"content_text":"SHINEWAY PHARM's stock price soared 5.09% during intraday trading on Friday, following the release of its annual financial results and other positive corporate announcements.The company reported an annual profit increase of 13.1% to 950 million yuan for the fiscal year ended December 31, 2025, despite a decrease in overall revenue. Furthermore, the group successfully secured bids for eight key products in the National Chinese Patent Medicine Purchasing Alliance's centralized procurement program, covering major therapeutic areas. This success is expected to enhance future market demand and sales potential for its products.Additionally, the company declared a first interim dividend of RMB 0.43 per share for the 2026 financial year, providing a return to shareholders. These combined positive developments likely contributed to increased investor confidence and the significant upward movement in the stock price.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}